P2X7 is involved in the anti-inflammation effects of levobupivacaine

Ya-Hsien Huang1, Jiin-Cherng Yen2, Jie-Jen Lee3

  • 1Department of Anesthesiology, Mackay Memorial Hospital, Taipei, Taiwan; Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan.

Abstract

Insights

Levobupivacaine inhibits microglia activation by reducing inflammatory molecules. The purinergic P2X7 receptor plays a key role in this process, as its activation reverses levobupivacaine

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Microglia activation is implicated in neuroinflammation.
  • Levobupivacaine's effects on microglia activation require elucidation.
  • The role of the purinergic P2X7 receptor in this context is unknown.

Purpose of the Study:

  • To investigate the involvement of the purinergic P2X7 receptor in levobupivacaine's inhibitory effects on microglia activation.
  • To assess the impact of levobupivacaine and P2X7 receptor modulation on inflammatory responses and neuronal viability.

Main Methods:

  • Microglia were stimulated with lipopolysaccharide (LPS) and treated with levobupivacaine, alone or with a P2X7 receptor agonist (Bz-ATP).
  • Inflammatory molecule expression (IL-1β, TNF-α, IL-6, MIP-2) and neuronal cell viability were measured.
  • P2X7 receptor activation was assessed using ethidium uptake assays.

Main Results:

  • Levobupivacaine significantly reduced inflammatory molecule upregulation in LPS-activated microglia.
  • The P2X7 receptor agonist Bz-ATP abrogated levobupivacaine's inhibitory effects.
  • Neuronal cell viability was enhanced by levobupivacaine, an effect diminished by Bz-ATP.
  • P2X7 receptor activation levels were higher in LPS-stimulated microglia and when P2X7 was co-treated with levobupivacaine and Bz-ATP.

Conclusions:

  • The purinergic P2X7 receptor is actively involved in mediating the effects of levobupivacaine on inhibiting microglia activation.
  • Targeting the P2X7 receptor may represent a therapeutic strategy in conditions involving neuroinflammation.

Related Concept Videos

Local Anesthetics: Common Agents and Their Applications01:23

Local Anesthetics: Common Agents and Their Applications

Local anesthetics (LAs) are commonly used for various applications in medical and dental procedures. Some of the common agents used are cocaine, lidocaine, and bupivacaine.
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
1.3K
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia01:16

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia

Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
2.2K
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
45
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Local Anesthetics: Differential Sensitivity of Nerve Fibers01:24

Local Anesthetics: Differential Sensitivity of Nerve Fibers

Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
1.7K
Local Anesthetics: Mechanism of Action01:23

Local Anesthetics: Mechanism of Action

Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
4.4K